trending Market Intelligence /marketintelligence/en/news-insights/trending/wndgc_zedtjms8o773zetw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Moody's upgrades Baxter's senior unsecured rating

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Moody's upgrades Baxter's senior unsecured rating

Moody's upgraded Baxter International Inc.'s senior unsecured rating to Baa1 from Baa2.

The ratings outlook is stable.

Moody's Senior Vice President Scott Tuhy said the upgrade takes into account the rating agency's expectations that operating initiatives undertaken by the company will allow it to sustain operating margins in the 16% to 17% range over the next 12 to 18 months.

The upgrade also reflects Moody's expectation that Baxter will maintain low leverage with debt/EBITDA near 2x, said Tuhy.

Moody's said the Baa1 rating reflects the company's good scale and leading market positions in a broad range of medical products, including renal care, medication delivery, pharmaceuticals and nutrition products.

Baxter International is a healthcare equipment company with a diverse portfolio of healthcare products.